JP2005525097A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005525097A5 JP2005525097A5 JP2003558219A JP2003558219A JP2005525097A5 JP 2005525097 A5 JP2005525097 A5 JP 2005525097A5 JP 2003558219 A JP2003558219 A JP 2003558219A JP 2003558219 A JP2003558219 A JP 2003558219A JP 2005525097 A5 JP2005525097 A5 JP 2005525097A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cancerous
- level
- cells
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000694 effects Effects 0.000 claims 7
- 230000000051 modifying Effects 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 230000002401 inhibitory effect Effects 0.000 claims 5
- 239000002157 polynucleotide Substances 0.000 claims 5
- 229920000023 polynucleotide Polymers 0.000 claims 5
- 210000000481 Breast Anatomy 0.000 claims 4
- 230000025458 RNA interference Effects 0.000 claims 3
- 230000000692 anti-sense Effects 0.000 claims 3
- 102000004965 antibodies Human genes 0.000 claims 3
- 108090001123 antibodies Proteins 0.000 claims 3
- 150000003384 small molecules Chemical class 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 230000002159 abnormal effect Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- 230000030944 contact inhibition Effects 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 230000003247 decreasing Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 238000003752 polymerase chain reaction Methods 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
Claims (30)
- DKFZp566I133活性の阻害のための因子を含有する、細胞の癌性表現型を阻害するための組成物。
- 前記細胞が胸部細胞である、請求項1に記載の組成物。
- 前記癌性表現型が、正常細胞に対する異常な細胞増殖である、請求項1〜2に記載の組成物。
- 前記癌性表現型が、細胞増殖の接触阻止の喪失である、請求項1〜3に記載の組成物。
- 前記因子が、低分子、抗体、アンチセンスポリヌクレオチド、およびRNAi分子からなる群より選択される、請求項1〜4に記載の組成物。
- 前記阻害が、DKFZp566I133タンパク質レベルの減少と関連する、請求項1〜5に記載の組成物。
- 前記阻害が、DKFZp566I133RNAレベルの減少と関連する、請求項1〜6に記載の組成物。
- 前記阻害が、DKFZp566I133タンパク質の活性レベルの減少と関連する、請求項1〜7に記載の組成物。
- 癌性細胞を検出するための方法であって、該方法は、以下;
被験体の細胞から得られた試験サンプルにおいて、DKFZp566I133またはそのフラグメントのレベルを検出する工程、
該DKFZp566I133のレベルとDKFZp566I133のコントロールレベルとを比較する工程を包含し、ここで、癌性細胞の存在は、該レベルの検出およびDKFZp566I133のコントロールレベルとの比較によって示される、方法。 - 前記癌性細胞が癌性胸部細胞である、請求項9に記載の方法。
- 前記遺伝子産物が核酸である、請求項9〜10に記載の方法。
- 前記遺伝子産物がポリペプチドである、請求項9〜11に記載の方法。
- 前記検出する工程が、ポリメラーゼ連鎖反応を使用する、請求項9〜12に記載の方法。
- 前記検出する工程がハイブリダイゼーションを使用する、請求項9〜13に記載の方法。
- 前記サンプルが、胸部組織のサンプルである、請求項9〜14に記載の方法。
- 前記産物のレベルが、前記試験サンプル細胞の癌性状態の指標である、請求項9〜15に記載の方法。
- 癌を有する被験体を処置する組成物であって、該組成物は、薬学的に有効な量の因子を含有し、ここで、該因子がDKFZp566I133の活性を調節する、組成物。
- 前記癌が胸部癌である、請求項17に記載の組成物。
- 前記因子が、低分子、抗体、アンチセンスポリヌクレオチド、およびRNAi分子からなる群より選択される、請求項17〜18に記載の組成物。
- 被験体の腫瘍負荷量を評価するための組成物であって、該組成物は、被験体からの試験サンプルにおけるDKFZp566I133のレベルを検出するための因子を含有し、ここで、該試験サンプルにおけるDKFZp566I133のレベルが、該被験体における腫瘍負荷量の指標である、組成物。
- 正常細胞と比較して癌性細胞において差次的に発現された遺伝子産物の生物学的活性を調節する因子を同定するための組成物であって、該組成物は、DKFZp566I133を含有し;ここで、候補因子の非存在下におけるDKFZp566I133の生物学的活性のレベルに対するDKFZp566I133の生物学的活性の調節は、該候補因子の調節された活性の指標である、組成物。
- 前記癌性細胞および前記正常細胞が胸部細胞である、請求項21に記載の組成物。
- 前記遺伝子産物の発現を評価する工程によって調節が検出される、請求項21〜22に記載の組成物。
- 発現が、ポリヌクレオチド遺伝子産物を検出する工程によって評価される、請求項23に記載の組成物。
- 発現が、ポリペプチド遺伝子産物を検出する工程によって評価される、請求項23〜24に記載の組成物。
- 前記候補因子が、低分子、抗体、アンチセンスポリヌクレオチド、およびRNAi分子からなる群より選択される、請求項21〜25に記載の組成物。
- 前記生物学的活性が、癌性表現型の調節である、請求項21〜26に記載の組成物。
- 前記癌性表現型が、異常な細胞増殖である、請求項27に記載の組成物。
- 前記癌性表現型が、接触阻止の喪失である、請求項27〜28に記載の組成物。
- 配列番号1〜499からなる群より選択される配列の少なくとも15連続するヌクレオチドを含む、単離されたポリヌクレオチド。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34563702P | 2002-01-08 | 2002-01-08 | |
PCT/US2003/000657 WO2003057926A1 (en) | 2002-01-08 | 2003-01-08 | Gene products differentially expressed in cancerous breast cells and their methods of use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009001171A Division JP2009142282A (ja) | 2002-01-08 | 2009-01-06 | 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005525097A JP2005525097A (ja) | 2005-08-25 |
JP2005525097A5 true JP2005525097A5 (ja) | 2006-02-23 |
JP4376629B2 JP4376629B2 (ja) | 2009-12-02 |
Family
ID=23355844
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003558219A Expired - Lifetime JP4376629B2 (ja) | 2002-01-08 | 2003-01-08 | 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法 |
JP2009001171A Pending JP2009142282A (ja) | 2002-01-08 | 2009-01-06 | 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009001171A Pending JP2009142282A (ja) | 2002-01-08 | 2009-01-06 | 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060141455A1 (ja) |
EP (2) | EP1472375B1 (ja) |
JP (2) | JP4376629B2 (ja) |
AT (1) | ATE427363T1 (ja) |
AU (1) | AU2003235791A1 (ja) |
CA (1) | CA2472282A1 (ja) |
DE (1) | DE60326931D1 (ja) |
ES (1) | ES2323456T3 (ja) |
HK (1) | HK1066032A1 (ja) |
PT (1) | PT1472375E (ja) |
SG (1) | SG148035A1 (ja) |
WO (1) | WO2003057926A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700359B2 (en) * | 2000-06-02 | 2010-04-20 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells |
MXPA05001933A (es) * | 2002-08-19 | 2005-04-28 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
JP2007532111A (ja) * | 2004-04-06 | 2007-11-15 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 乳癌における標的としてのオーファン受容体チロシンキナーゼ |
US7232808B2 (en) * | 2004-08-02 | 2007-06-19 | University Of Iowa Research Foundation | Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD) |
GB2424886A (en) * | 2005-04-04 | 2006-10-11 | Dxs Ltd | Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations |
US7694048B2 (en) * | 2005-05-06 | 2010-04-06 | Fotonation Vision Limited | Remote control apparatus for printer appliances |
AT502722B8 (de) * | 2005-10-31 | 2009-08-15 | Bmt Medizinische Forschung Und | Verwendung des interferon induzierten gens 12 (isg 12, ifi 27) zur modulation transkriptioneller aktivitäten von nuklearen rezeptoren |
US20080113349A1 (en) * | 2006-11-03 | 2008-05-15 | Pranvera Ikonomi | Method for detecting the presence of mammalian organisms using specific cytochrome c oxidase I (COI) and/or cytochrome b subsequences by a PCR based assay |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4714681A (en) * | 1981-07-01 | 1987-12-22 | The Board Of Reagents, The University Of Texas System Cancer Center | Quadroma cells and trioma cells and methods for the production of same |
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
WO1986005807A1 (en) | 1985-04-01 | 1986-10-09 | Celltech Limited | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
US4777127A (en) * | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
GB8601597D0 (en) * | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
US5993829A (en) * | 1987-04-23 | 1999-11-30 | Bystryn; Jean-Claude | Anti-cancer vaccine |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
US5124246A (en) | 1987-10-15 | 1992-06-23 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
US5206152A (en) * | 1988-04-08 | 1993-04-27 | Arch Development Corporation | Cloning and expression of early growth regulatory protein genes |
US5010175A (en) | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
US5422120A (en) * | 1988-05-30 | 1995-06-06 | Depotech Corporation | Heterovesicular liposomes |
AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
US4925648A (en) * | 1988-07-29 | 1990-05-15 | Immunomedics, Inc. | Detection and treatment of infectious and inflammatory lesions |
US5601819A (en) | 1988-08-11 | 1997-02-11 | The General Hospital Corporation | Bispecific antibodies for selective immune regulation and for selective immune cell binding |
EP0454781B1 (en) | 1989-01-23 | 1998-12-16 | Chiron Corporation | Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
CA2489769A1 (en) | 1989-03-21 | 1990-10-04 | Philip L. Felgner | Expression of exogenous polynucleotide sequences in a vertebrate |
EP0479909B1 (en) | 1989-06-29 | 1996-10-30 | Medarex, Inc. | Bispecific reagents for aids therapy |
EP1001032A3 (en) | 1989-08-18 | 2005-02-23 | Chiron Corporation | Recombinant retroviruses delivering vector constructs to target cells |
US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
JP3068180B2 (ja) * | 1990-01-12 | 2000-07-24 | アブジェニックス インコーポレイテッド | 異種抗体の生成 |
NZ237464A (en) | 1990-03-21 | 1995-02-24 | Depotech Corp | Liposomes with at least two separate chambers encapsulating two separate biologically active substances |
US5252296A (en) | 1990-05-15 | 1993-10-12 | Chiron Corporation | Method and apparatus for biopolymer synthesis |
US5149655A (en) | 1990-06-21 | 1992-09-22 | Agracetus, Inc. | Apparatus for genetic transformation |
ATE174339T1 (de) | 1990-07-27 | 1998-12-15 | Chiron Corp | Grosse kammförmig verzweigte polynukleotide |
WO1992005793A1 (en) | 1990-10-05 | 1992-04-16 | Medarex, Inc. | Targeted immunostimulation with bispecific reagents |
AU8727291A (en) | 1990-10-29 | 1992-06-11 | Cetus Oncology Corporation | Bispecific antibodies, method of production, and uses thereof |
AU657111B2 (en) | 1990-12-20 | 1995-03-02 | Dana-Farber Cancer Institute | Control of gene expression by ionizing radiation |
GB9103974D0 (en) * | 1991-02-26 | 1991-04-10 | Norsk Hydro As | Therapeutically useful peptides or peptide fragments |
EP0511011B1 (en) * | 1991-04-26 | 1996-10-23 | Surface Active Limited | Novel antibodies and methods for their use |
CA2115742A1 (en) | 1991-08-20 | 1993-03-04 | Ronald G. Crystal | Adenovirus mediated transfer of genes to the gastrointestinal tract |
WO1993010218A1 (en) | 1991-11-14 | 1993-05-27 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Vectors including foreign genes and negative selective markers |
GB9125623D0 (en) | 1991-12-02 | 1992-01-29 | Dynal As | Cell modification |
FR2685346B1 (fr) | 1991-12-18 | 1994-02-11 | Cis Bio International | Procede de preparation d'arn double-brin, et ses applications. |
CA2128616A1 (en) | 1992-01-23 | 1993-08-05 | Gary H. Rhodes | Ex vivo gene transfer |
DK0627940T3 (da) | 1992-03-05 | 2003-09-01 | Univ Texas | Anvendelse af immunokonjugater til diagnose og/eller terapi af vaskulariserede tumorer |
FR2688514A1 (fr) | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
WO1993025234A1 (en) | 1992-06-08 | 1993-12-23 | The Regents Of The University Of California | Methods and compositions for targeting specific tissue |
EP0644946A4 (en) | 1992-06-10 | 1997-03-12 | Us Health | VECTOR PARTICLES RESISTANT TO HUMAN SERUM INACTIVATION. |
GB2269175A (en) | 1992-07-31 | 1994-02-02 | Imperial College | Retroviral vectors |
JPH08503855A (ja) | 1992-12-03 | 1996-04-30 | ジェンザイム・コーポレイション | 嚢胞性線維症に対する遺伝子治療 |
EP0695169B1 (en) | 1993-04-22 | 2002-11-20 | SkyePharma Inc. | Multivesicular cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use |
DE69434486T2 (de) | 1993-06-24 | 2006-07-06 | Advec Inc. | Adenovirus vektoren für gentherapie |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
EP0814154B1 (en) | 1993-09-15 | 2009-07-29 | Novartis Vaccines and Diagnostics, Inc. | Recombinant alphavirus vectors |
US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
ATE314482T1 (de) | 1993-10-25 | 2006-01-15 | Canji Inc | Rekombinante adenoviren-vektor und verfahren zur verwendung |
ES2149955T3 (es) | 1993-11-16 | 2000-11-16 | Skyepharma Inc | Vesiculas con liberacion controlada de sustancias activas. |
US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
US5631734A (en) | 1994-02-10 | 1997-05-20 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
AU2585395A (en) | 1994-05-09 | 1995-11-29 | Chiron Corporation | Retroviral vectors having a reduced recombination rate |
US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5985660A (en) * | 1994-06-15 | 1999-11-16 | Systemix, Inc. | Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation |
US5807522A (en) * | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US6974666B1 (en) | 1994-10-21 | 2005-12-13 | Appymetric, Inc. | Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA |
US5556752A (en) * | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
WO1996017072A2 (en) | 1994-11-30 | 1996-06-06 | Chiron Viagene, Inc. | Recombinant alphavirus vectors |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
US5804162A (en) | 1995-06-07 | 1998-09-08 | Alliance Pharmaceutical Corp. | Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients |
US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US5811097A (en) * | 1995-07-25 | 1998-09-22 | The Regents Of The University Of California | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
US5654173A (en) * | 1996-08-23 | 1997-08-05 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
JP2002515738A (ja) | 1996-01-23 | 2002-05-28 | アフィメトリックス,インコーポレイティド | 核酸分析法 |
AU2189397A (en) | 1996-02-08 | 1997-08-28 | Affymetrix, Inc. | Chip-based speciation and phenotypic characterization of microorganisms |
US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
US6458530B1 (en) | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
DE69739286D1 (de) | 1996-05-06 | 2009-04-16 | Oxford Biomedica Ltd | Rekombinationsunfähige retrovirale vektoren |
US5846536A (en) | 1996-10-04 | 1998-12-08 | The Regents Of The University Of California | Restoration of normal phenotype in cancer cells |
US6197543B1 (en) * | 1997-10-28 | 2001-03-06 | Incyte Pharmaceuticals, Inc. | Human vesicle membrane protein-like proteins |
EP1100523A4 (en) | 1998-08-07 | 2005-02-02 | Gen Hospital Corp | TREATMENT OF ISCHEMIA OR INJURY OF THE CENTRAL NERVOUS SYSTEM WITH EPIDERMAL GROWTH FACTOR-SIMILAR POLYPEPTIDES |
US6844325B2 (en) * | 1998-12-28 | 2005-01-18 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
JP2002533402A (ja) | 1998-12-31 | 2002-10-08 | カイロン コーポレイション | 癌を処置するためおよび樹状細胞の走化性を媒介するための方法 |
AU3395900A (en) | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
EP1196570A2 (en) | 1999-07-26 | 2002-04-17 | Genentech, Inc. | Human polypeptides and methods for the use thereof |
US7700359B2 (en) * | 2000-06-02 | 2010-04-20 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells |
KR20030029847A (ko) | 2000-08-24 | 2003-04-16 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 조성물 및 방법 |
AU2002322280A1 (en) * | 2001-06-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
-
2003
- 2003-01-08 WO PCT/US2003/000657 patent/WO2003057926A1/en active Application Filing
- 2003-01-08 PT PT03729383T patent/PT1472375E/pt unknown
- 2003-01-08 ES ES03729383T patent/ES2323456T3/es not_active Expired - Lifetime
- 2003-01-08 CA CA002472282A patent/CA2472282A1/en not_active Abandoned
- 2003-01-08 EP EP03729383A patent/EP1472375B1/en not_active Expired - Lifetime
- 2003-01-08 AU AU2003235791A patent/AU2003235791A1/en not_active Abandoned
- 2003-01-08 SG SG200604596-7A patent/SG148035A1/en unknown
- 2003-01-08 JP JP2003558219A patent/JP4376629B2/ja not_active Expired - Lifetime
- 2003-01-08 DE DE60326931T patent/DE60326931D1/de not_active Expired - Lifetime
- 2003-01-08 EP EP09156623A patent/EP2075346A3/en not_active Withdrawn
- 2003-01-08 AT AT03729383T patent/ATE427363T1/de active
- 2003-01-08 US US10/501,187 patent/US20060141455A1/en not_active Abandoned
-
2004
- 2004-11-12 HK HK04108954.3A patent/HK1066032A1/xx not_active IP Right Cessation
-
2009
- 2009-01-06 JP JP2009001171A patent/JP2009142282A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2688477C (en) | Multigene prognostic assay for lung cancer | |
NL2007467C2 (en) | Compositions and methods for detecting cancer metastasis. | |
JP2006500949A5 (ja) | ||
JP2009502115A5 (ja) | ||
JP2008512984A5 (ja) | ||
CA2488404A1 (en) | Genes and polypeptides relating to human colon cancers | |
JP2007506426A5 (ja) | ||
WO2007015947A2 (en) | Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies | |
JP2009502116A5 (ja) | ||
JP2010259438A5 (ja) | ||
JP2012501164A5 (ja) | ||
JP2005537007A5 (ja) | ||
Lissa et al. | HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients | |
WO2005121360A3 (en) | Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients | |
JP2005525097A5 (ja) | ||
AU2012275323B2 (en) | Somatic mutations in ATRX in brain cancer | |
US8747867B2 (en) | Cancer markers | |
Feng et al. | Epigenetic and genetic alterations-based molecular classification of head and neck cancer | |
KR20110089577A (ko) | Pna 기반의 실시간 pcr 클램핑을 이용한 braf 돌연변이 검출 방법 및 키트 | |
Carinci et al. | Genetic portrait of mild and severe lingual dysplasia | |
JP2006503575A5 (ja) | ||
Ishikawa et al. | Gene expression profile changes correlating with radioresistance in human cell lines | |
JP2004503238A5 (ja) | ||
JP2005504830A5 (ja) | ||
US7888033B2 (en) | Use of ID4 for diagnosis and treatment of cancer |